Linden Thomas Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
16,792
-167
| -1% | -$19K | 0.21% | 152 |
|
|
2025
Q1 | $1.78M | Sell |
16,959
-49
| -0.3% | -$5.15K | 0.23% | 149 |
|
|
2024
Q4 | $1.82M | Sell |
17,008
-20
| -0.1% | -$2.14K | 0.23% | 148 |
|
|
2024
Q3 | $1.7M | Sell |
17,028
-84
| -0.5% | -$8.41K | 0.23% | 162 |
|
|
2024
Q2 | $1.44M | Buy |
17,112
+271
| +2% | +$22.8K | 0.22% | 187 |
|
|
2024
Q1 | $1.23M | Buy |
16,841
+448
| +3% | +$32.7K | 0.2% | 219 |
|
|
2023
Q4 | $1.17M | Sell |
16,393
-386
| -2% | -$27.6K | 0.22% | 200 |
|
|
2023
Q3 | $1.01M | Sell |
16,779
-29
| -0.2% | -$1.74K | 0.22% | 200 |
|
|
2023
Q2 | $1.21M | Buy |
+16,808
| New | +$1.21M | 0.27% | 149 |
|